SMAD6
SMAD6 (SMAD family member 6, also known as MADH6, MADH7 and HsT17432) is an inhibitory member of the SMAD family that restrains signalling by the TGF-beta superfamily, with strong selectivity for BMP-dependent pathways. Browse Assay Genie's current range of SMAD6 research reagents below, or read on for the biology behind the target.
SMAD6 acts as an inhibitory regulator of signalling mediated by the TGF-beta superfamily, showing strong selectivity toward BMP-dependent pathways. It blocks the BMP-SMAD1 pathway by competing with SMAD4 for binding to receptor-activated SMAD1. It also associates with regulatory elements in target promoter regions. In addition, SMAD6 suppresses IL1R-TLR signalling through direct interaction with PEL1, which prevents NF-kappa-B activation, nuclear translocation and NF-kappa-B-mediated expression of pro-inflammatory genes.
SMAD6 can also work as an adapter protein that recruits ubiquitin ligases, including SMURF1 and, in some contexts, SMURF2. This promotes proteasomal degradation of signalling components and transcription factors such as RUNX2, TBX6, BMPR1A and MYD88. The protein is found in the nucleus and the cytoplasm. The SMAD6 gene encodes a member of the dwarfin/SMAD family, and multiple transcript variants have been described. The mouse ortholog is Smad6.
SMAD proteins are related to Drosophila 'mothers against decapentaplegic' (Mad) and C. elegans Sma, and act as signal transducers and transcriptional modulators for multiple pathways. SMAD6 functions in the negative regulation of BMP and TGF-beta/activin signalling. This explains the earlier names MAD and mothers against DPP homolog 6 (Drosophila), and the aliases MADH6 and MADH7. Researchers studying the SMAD6 protein often consider it alongside the receptor-regulated SMAD1 and SMAD5, the co-SMAD Smad4 and the other inhibitory SMAD, SMAD7.
SMAD6 blocks the BMP-SMAD1 pathway by competing with SMAD4 for receptor-activated SMAD1, making it a key tool for studying BMP pathway control.
By interacting with PEL1, SMAD6 suppresses IL1R-TLR signalling and prevents NF-kappa-B activation and pro-inflammatory gene expression.
SMAD6 recruits SMURF1 and in some contexts SMURF2, promoting proteasomal degradation of targets including RUNX2, TBX6, BMPR1A and MYD88.
As an inhibitory SMAD, SMAD6 helps define negative regulation of BMP and TGF-beta/activin signalling within the wider SMAD family.
SMAD6 is an inhibitory regulator of TGF-beta superfamily signalling, with strong selectivity toward BMP pathways. It competes with SMAD4 for binding to receptor-activated SMAD1, recruits ubiquitin ligases such as SMURF1 to promote degradation of signalling components, and suppresses IL1R-TLR signalling through PEL1.
SMAD6 is also known as MADH6, MADH7 and HsT17432. Earlier names include MAD and mothers against decapentaplegic homolog 6 (Drosophila). The gene has multiple transcript variants, so literature and databases may use different labels for the same locus.
SMAD6 belongs to the dwarfin/SMAD family, related to Drosophila Mad and C. elegans Sma, and the mouse ortholog is Smad6. For work in a given species, check the datasheet of any product for its validated reactivity.
Other SMAD family members, including receptor-regulated, common-mediator and inhibitory SMADs, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43541; product specifications from Assay Genie datasheets.